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In previous papers (1, 2) we showed that the Berkefeld filtrates of 
certain anaerobically produced autolysates of pneumococcus of Types 
I, II, or III cause in guinea pigs:  (a) necrosis of the skin when injected 
intracutaneously; (b) hemorrhagic edema of the lungs and death when 
injected intratracheally;  and  (c)  pneumonia associated  with  unre- 
strained multiplication of the organism in the lung when injected intra- 
tracheally in sublethal doses combined with living pneumococci.  The 
absorption of this autolysate poison with red blood cells removed the 
factor injurious to the lung but left the power to produce necrosis of 
the skin unimpaired, showing that at least 2 toxic substances were 
present in the autolysates (3).  We also demonstrated that immuniza- 
tion of rabbits and especially of horses with these autolysates stimu- 
lates the production of sera of marked antitoxic properties both for 
the principle causing skin necrosis  and the principle causing hemor- 
rhagic edema of the lungs  (1,  4,  5).  Moreover, an  anti-autolysate 
serum prepared by the immunization with the autolysate from one 
type of pneumococcus neutralized the poisons affecting the skin and 
the lung produced from each of the other three types,  which demon- 
strated  that  these antitoxins, and presumably the toxins, were not 
type specific  (1, 4,  3). 
In a series of papers in 1931 and 1934, Blackman and his associates 
have shown that our anaerobically prepared pneumococcus autolysate 
poison when injected intravenously into rabbits  produces nephritis 
or nephrosis, depending on the dosage of the toxin and the immunity 
of the animal to the poison (6-8). 
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Recently  we  found  that  these  pneumococcus  autolysates  are  also 
toxic  for  mice  when  injected  intravenously  in  comparatively  small 
doses and that their toxic effects may be neutralized by the antitoxin 
to the  autolysate in relatively high  dilutions.  Since  the intravenous 
method of injection in mice for the evaluation of pneumococcus autoly- 
sate  antitoxin  has  many  advantages,  such  as  simplicity,  economy, 
accuracy, over the previous intratracheal method in guinea pigs,  this 
study was undertaken.  In addition  to giving the details of the titra- 
tion of the pneumococcus autolysate antitoxin in mice when this anti- 
toxin  and  autolysate  toxin  are mixed before injection,  we shall  show 
that  this  antitoxin  is  also  efficacious  when  given  separately  either 
at the same time as or 2 hours after the injection of the poison. 
Methods 
The preparation of the toxic autolysates has been described in detail in previous 
papers.  Briefly, the method is to autolyze in broth at room temperature under 
vaseline  seal,  the  centrifuged pneumococci obtained  after  18  hours growth  in 
double strength veal infusion  broth containing 4 per cent Witte peptone.  No 
phenol was added to any of these preparations.  In the experiments here reported 
all autolysate poisons were prepared from a Type II pneumococcus recovered from 
a  case  of  lobar  pneumonia at  the  Presbyterian  Hospital.  The pneumococcus 
strain was kept virulent by passage through rabbits. 
Toxicity of the Autalysates for Mice.--The autolysate  toxin  injected  intrave- 
nously in 0.1 to 0.2 cc: quantities kills 18-20 gm. mice in a few minutes to 8 days 
depending on the strength of the toxin and the usual individual differences in the 
susceptibility of  the  mice.  In the  mice that  die  quickly, within  2  hours,  the 
symptoms develop soon after the injection and consist of weakness and increasing 
prostration until death.  The mice that survive 2 or 3 days have the same symp- 
toms as those described above, preceded by an incubation period of 2 or 3 hours 
in which they appear normal.  Sometimes convulsions  occur in these latter ani- 
mals before death. 
At autopsy, in the mice that die within a few hours, nothing abnormal is seen 
in the gross, except tiny hemorrhages in the lungs.  In those that survive 2 to 4 
days, usually the organs appear normal in the gross except for the kidneys which 
are enlarged and of a pale color.  In these latter mice and in those that survive 
longer than 4 days, marked edema of the subcutaneous tissues or ascites or both 
edema and ascites may occur, lasting for variable periods.  The kidneys of the 
mice that survive 5 to 8 days are usually markedly enlarged, 2 to 3 times their 
normal size, and of a white or pale yellow color.  Many of the mice having the 
large white or pale yellow kidneys are much emaciated at the time of death.  Most 
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weight after injection.  In these emaciated mice the tissues are pale and, except 
for the kidneys that, as stated before, are remarkably enlarged, the organs and 
tissues appear shrunken.  Massive albuminuria appearing 18 hours after injection 
and continuing for 4 or 5 days was found. 
The pathology of mice inoculated with the pneumococcus autolysate poison 
will be taken up in detail in a later publication. 
Autolysate Antitoxic Sera.--Autolysate antitoxins 1,  2,  and 3--concentrated 
and refined sera obtained from horses immunized for us by Eli Lilly and Company 
in  1928 and  1929 with the sterile toxic autolysate filtrates from  Pneumococcus 
Types I, II, and III. 
Autolysate antitoxin 4--concentrated and refined serum obtained from horses 
immunized by Eli Lilly and  Company in  1928 and  1929 with the sterile toxic 
autolysate filtrates from Pneumococcus Types I, II, and III combined with dead 
pneumococcus organisms, Types I, II, III, and IV.  Autolysate antitoxins 1, 2, 3, 
and 4 are the same that we titrated previously in 1928 and 1929 for antitoxins 
to the toxic effect  for the lung.  Recent tests by the intratracbeal method in guinea 
pigs demonstrate that these antitoxins have lost in the last 5 years over one-half 
their neutralizing antibodies for the lung poison. 
Autolysate antitoxin 5--preparation 2 re-refined in August, 1934, by Eli Lilly 
and Company. 
.4  ntibacterial Sera.l--Antibacterial serum 6---New York Board of Health, Types 
I and II, refined, containing 1500 units per cc. of Type I and 800 units per cc. of 
Type II. 
Antibacterial serum 7--New York Board of Health, Type I, refined, containing 
2500 units per cc. of Type I. 
Antibacterial serum 8---New York Board of Health, Types II and V, refined, 
containing 800 units per cc. of Type II and 1500 units per cc. of Type V. 
Normal horse serum, inactivated. 
Evaluation  of Pneumococcus A utolysate Antitoxin  When the A utolysate 
Toxin and Serum Are Incubated  Together before Infection 
In  this  work  1  unit  of  toxin is  taken  as  the  smallest  amount  of 
pneumococcus  toxic  autolysate  that  kills  18-20  gin.  mice  regularly 
in  less  than  2  days  when  inoculated  intravenously;  and  1  unit  of 
antitoxin  represents  the  smallest  amount  of serum  that,  when incu- 
bated  at  37°C.  for 30 minutes  with  1  unit  of toxin,  neutralizes  the 
toxin  so  that  no  symptoms  occur when  it  is  injected  intravenously 
into  mice. 
1  The pneumococcus  antibacterial sera were obtained from Dr. Jesse BuUowa 
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The  tests  for the  presence  of neutralizing antibodies were  carried 
out as follows: 
Dilutions of the sera in physiological salt solution were first prepared.  0.1  cc. 
of the various serum dilutions or salt solution instead of the serum dilutions were 
pipetted into separate  precipitin  tubes.  To each tube 0.9 cc. of toxic pneumo- 
coccus autolysate, if necessary, diluted with saline so that it contained 10 units, 
was added and the contents of each tube immediately mixed.  The tubes were 
placed in the water bath at 37°C. for 30 minutes and then in ice water until used. 
0.2 cc. from each tube, representing 2 units of toxin, was inoculated intravenously 
into one or more mice weighing 18-20 gin. 
Normal horse serum and specific antibacterial pneumococcus sera were used 
to control the pneumococcus autolysate antitoxins. 
A  typical experiment demonstrating the neutralizing action of sev- 
eral  pneumococcus  autolysate antitoxins on  one  toxic  autolysate is 
presented in Table I.  Because of lack of sufficient autolysate toxin 
the antitoxins were not titrated to  their end-points.  However, it is 
seen that autolysate antitoxins 1, 2, and 3, contain at least 200 mouse 
units per cc., whereas the antibacterial serum 6,  containing 1500 and 
800  protective units for Pneumococcus Types I  and II, respectively, 
even in  1-10  dilution has  no  neutralizing properties  for our  autoly- 
sate  toxin. 
In Table II, using a different autolysate toxin, it is seen that 3 anti- 
bacterial  sera  in  1-10  dilutions and normal horse  serum  in  1-20  or 
1-50  dilutions have  slight if any detoxicating effect on  this poison. 
However, horse serum when incubated with this toxin in 1-10 dilution 
does appear to have resulted in the delayed death of 2 mice injected 
with such mixtures.  (See Table II, Mice 1 and 2.) 
The  Protection  of  Mice  against  the  Lethal  Action  of  Pneumococcus 
Autolysate  Toxin by the Separate Treatment with Pneumococcus 
A utolysate A ntitoxzn 
Table  III  gives  the  results  obtained  in  an  experiment  in  which 
autolysate  anfitoxic serum  was  given  intraperitoneally immediately 
after  the  intravenous injection of a  lethal dose of  autolysate toxin, 
normal horse  serum  and  antibacterial  serum  being used  as controls. 
All the  sera were diluted  1-5  with salt solution and 0.5  cc.  of these 
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used in this experiment was a  very weak preparation.  Table III is 
self-explanatory. 
In Table IV is presented an experiment in which the pneumococcus 
autolysate antitoxin and  2  antibacterial sera as controls were given 
TABLE  I 
Titration of Pneumococcus Autolysate Antitoxin 
Serum dilutions 
Serum 
Autolysate  anti- 
toxin 2 
Autolysate  anti- 
toxin 1 
Autolysate  anti- 
toxin 3 
Autolysate  anti- 
toxin 4 
Autolysate  anti- 
toxin 5 
Antibacterial  se- 
rum 6 
Control toxin and 
saline 
1-10 
D  2 hrs. 
D  5  " 
D  2min. 
D  5  " 
D40  " 
D  6 hrs. 
1-20  l-SO 
D  6 hrs.  D  6 hrs. 
1-100 
D  4 days 









D  18 hrs. 
D  3 days 
D  3  " 
D  18 hrs. 
The autolysate toxin and sera were incubated together before injections---0.9 
cc. of toxin and 0.1 cc. of serum, serum dilution, or saline.  In water bath at 37°C. 
for 30 minutes.  Mice inoculated intravenously with 0.2 cc. of mixtures. 
intravenously  2  hours  after  the  injection  of  the  autolysate poison. 
Of the 15 mice injected, the 6 mice that appeared the sickest 2 hours 
after the intravenous injection of the toxic autolysate were given the 
antitoxin so  that  the experiment was planned to favor the survival 
of the control mice.  This experiment demonstrates that 5  of the 6 124  Pl~Etr~ococcus  AUTOLYSATE TOXIN  AND  ANTITOXIN 
mice injected with autolysate antitoxin survived, whereas all the con- 
trol  mice  died.  The  mouse  that  died  after antitoxin  treatment  was 
already extremely sick when injected with antitoxin.  In this experi- 
ment, Table IV, it is seen that there is great variation in the  time of 
TABLE II 
The Effect of Normal Horse Serum and 3  Antibacterial Pneumococcus Sera When 















Pneumococcus autolysate toxin and normal horse serum 
g¢  g¢ 
Pneumococcus autolysate  toxin and antibacterial  serum 
Type I (No. 7) 
¢¢  tg 
Pneumococcus autolysate  toxin and antibacterial  serum 
Types I and II (No. 6) 
gl  ll 
Pneumococcus autoly~te toxin and antibacterial  serum 
Types II and V (No. 8) 
gg  lg 
{g  g¢ 
Pneumococcus autolysate toxin and saline 
lg  ll 
Iff  t¢ 
Dead 
5 days 
5  " 
2  " 
18 hrs. 
2 days 
2  " 
18 hrs. 
4 days 
4  " 
4  " 
18 hrs. 
4  " 
4 days 
2  ~ 
4  " 




0.9 cc. of autolysate toxin and 0.l cc. of serum, serum dilution, or saline.  In 
water bath at 37  ° for 30 minutes.  Mice inoculated intravenously with 0.2  cc. 
of mixtures. 
death in  the  5  mice inoculated  with  the  antibacterial  Type I  and  II 
serum  (No.  6).  That mice inoculated  intravenously with this serum 
2  hours after the injection of autolysate poison often die  sooner than 
the other controls, has been our experience in other experiments.  No 
explanation of this observation is apparent at present.  The serum in JULIA  T. WELD  AND  ANNE  GUNTHER  125 
TABLE  III 
The  Effect  of Pneumococcus  Autolysate  Antitoxin  Given  Intraperitoneally 
Immediately after the Intravenous Inoculation of a Lethal 
Injection of Pneumococcus  Toxin 
Pneum~ 
COCCUS 











Serum intraperitoneally  0.5 cc. of 1-5 dilution 
Normal horse 
4g  44 
Antibacterial serum Types I and II (No. 6) 
44  4~ 
Autolysate antitoxin 1 
~4  4~ 
Died or 
survived 
D 3 days 
D2  " 
D2  " 
D 4 hrs. 
Survived 
4¢ 
D 4 days 
D 3  "  m 
TABLE  IV 
The Effect of Pneumococcus  Autolysate Antitoxin Given Intravenously 2 Hours after 
the Intravenous Inoculation of a Lethal Dose of Pneumococcus  Autolysate Toxin 
Serum intravenously  0.5 cc. of 1-5 dilution 
Pneumo- 
COCCUS  Mouse  No.  autolysate 
toxin 
Ce. 
1  0.2 
2  0.2 
3  0.2 
4  0.2 
5  0.2 
6  0.2 
7  0.2 
8  0.2 
9  0.2 
10  0.2 
11  0.2 
12  0.2 
13  0.2 
14  0.2 
15  0.2 
Autolysate antitoxin 1 
4C  4~ 
44  4~ 
4a  4~ 
Antibacterial serum Type I  (No. 7) 
4g  4~ 
Antibacterial serum Types I  and II (No. 6) 
44  4~ 
4~  44 
44  4~ 
Died or 
survived 






O  5J 
D  18 
D  1 
D 30 
D  15 
D  5 
D  5 
D  4 
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the quantity used is not toxic in itself for mice.  On the other hand, 
the delayed death of Mouse .12  in this experiment appears to be due 
to an individual resistance of this mouse to the poison. 
When mice are injected with autolysate toxin mixed with adequate 
(neutralizing)  amounts  of  autolysate  antitoxin  or  separately  with 
toxin and  adequate amounts of antitoxin and  are killed at  varying 
intervals after such injections, no edema, emaciation, or macroscopic 
kidney changes are seen at autopsy.  Neither is there albumin in the 
urine of these animals.  On the other hand, when mice are inoculated 
with partly neutralized mixtures of autolysate toxin and autolysate 
antitoxin or with toxin followed by inadequate amounts of antitoxin, 
prolonged intoxication results with death in 5 to 8 days and the usual 
findings  of  animals  dying  slowly  from  injection  of  pneumococcus 
autolysate  toxin  alone;  i.e.  emaciation,  large  white  or  pale  yellow 
kidneys, albuminuria, and occasional edema. 
DISCUSSION 
The experiments reported in this paper appear to demonstrate that 
certain  anaerobically  prepared  autolysates  of  pneumococcus cause 
death when injected intravenously into mice and that antitoxin pro- 
duced in horses by immunization with the toxic autolysates neutralizes 
the poison so that  no toxic effects result from its  inoculation.  At 
present we have no conclusive evidence as to whether or not the sub- 
stance  or  substances in  the  autolysate  toxic for mice are  identical 
with the substance or substances injurious to the lungs of guinea pigs. 
In favor of the view that the toxic effects in mice and in guinea pigs 
are due to the same poisonous principle are the findings (not reported 
in this paper) that heating the toxic autolysates to 60°C. for 10 minutes 
destroys both toxic effects, and that the substance toxic for mice is 
absorbed  from  toxic  autolysate  filtrates  by  red  cells  and  red cell 
stroma as is the substance injurious to the lungs of guinea pigs. 
In previous papers it was established that the principle in the autoly- 
sates  injurious  to  lungs  is  antigenically  similar  for  Pneumococcus 
Types I, II, and III.  Unfortunately at the time of  carrying on the 
experiments reported in this paper no pneumococcus autolysate mon- 
ovalent antitoxic serum was available, which fact prevented our deter- 
mining whether the poisonous principle for mice in the toxic autoly- 
sates is also species specific for Pneumococcus Types I,  II,  and III JULIA T.  WELD AND  ANNE GUNTHER  127 
and not type specific.  However,  we did test  autolysate  antitoxin  1 
against  a  toxic  autolysate  prepared  from  Pneumococcus  Type  19 
strain  s  and  found that  it  neutralized  this  autolysate  toxin  similarly 
to the Pneumococcus Type II autolysate toxin.  Therefore, as far as 
these experiments go, the evidence is that the substance in the autoly- 
sates that kills mice is species specific and not type specific. 
CONCLUSIONS 
1.  Certain  anaerobically  produced  autolysates  of  pneumococcus 
injected intravenously kill mice in 0.1  to 0.2  cc.  quantities  in a  few 
hours  to  8  days. 
2.  The  symptoms  of  mice  inoculated  with  these  autolysates  are 
weakness and increasing prostration  until death.  Massive  albumin- 
uria is found, appearing  18 hours after injection.  During the course 
of  a  prolonged intoxication  ascites  and  edema of  the  subcutaneous 
tissues may develop.  Large pale yellow or white kidneys are  found 
in mice that  survive 5  days.  In  these latter  animals,  emaciation is 
usually marked at death. 
3.  The  antitoxin  prepared  in  horses  by  immunization  with  the 
anaerobically prepared toxic autolysates of pneumococcus neutralizes 
the poisonous autolysates whether mixed in vitro  before injection or 
injected separately  after  the  auto]ysate. 
4.  The  injection  of  pneumococcus  autolysate  toxin  incompletely 
neutralized with autolysate antitoxin causes a protracted intoxication 
with symptoms and pathologic findings similar to those found in mice 
dying slowly after injections of the toxic autolysate alone. 
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